About Arch Pharmalabs
Arch Pharmalabs is a Healthcare company based in Mumbai (India) founded in 1999, and was acquired by Neuland in December 2017. It operates as an API manufacturer supplier, also offering custom synthesis and contract manufacturing services. Arch Pharmalabs has raised $68 million across 1 funding round from investors including Mitsui & Co and Neuland Labs. The company has 412 employees. Its Indian entity Arch Pharmalabs Limited reported revenue of ₹1,344 Cr. Arch Pharmalabs offers products and services including APIs, Intermediates, and Contract Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its competitors include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Arch Pharmalabs, is a provider of small molecule process chemistry, custom synthesis services and full life-cycle API and drug intermediates and manufacture for the global pharmaceutical industry. In Sep2010 Japanese conglomerate Mitsui has bought a 5 stake in Arch Pharmalabs, for around INR 65 crore and additional 25 in Sept2012 for INR 372 Crore. Mitsui bought out the stakes of ILFS Trust Co, IDBI Trusteeship Services Rainbow Fund, ICICI ventures
- Headquarters Mumbai, India
- Employees 412
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website archpharmalabs.com
- Social LinkedIn
- Acquired by Neuland (Dec 2017)
- Legal Name Arch Pharmalabs Limited
- Date of Incorporation 02 Apr, 1993
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,344 Cr
FY 2023 · +2% YoY
- Net Profit₹122 Cr
FY 2023 · 9% margin
- EBITDA₹183 Cr
FY 2023 · 14% margin
- Total Equity Funding$68M (USD)
in 1 rounds
- Latest Funding Round$68M (USD), Series C
Jan 2013
- InvestorsMitsui & Co.
& 1 more
- Employee Count412
- Acquired byNeuland
(Dec 2017)
Associated legal entities of Arch Pharmalabs
Arch Pharmalabs operates through Arch Pharmalabs Limited (under cirp). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Arch Pharmalabs Limited CIN U24231MH1993PLC150891 | Under Cirp | 02 Apr 1993 | Mumbai, Maharashtra | ₹1,344 Cr | 412 | 9 | View details |
Products & Services of Arch Pharmalabs
Arch Pharmalabs offers a comprehensive portfolio of products and services, including APIs, Intermediates, and Contract Services.
Production of active pharmaceutical ingredients for drug development
Manufacture of chemical intermediates used in pharmaceuticals
Provision of contract research and manufacturing for partners
Funding Insights of Arch Pharmalabs
Arch Pharmalabs has successfully raised a total of $68M through 1 strategic funding round. The most recent funding activity was a Series C round of $68 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $68M
- Total Rounds 1
- Last Round Series C — $68M
- First Round $68M
(Jan 2013)
- Investors Count 1
All 1 funding rounds of Arch Pharmalabs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $68M | Series C | – | Mitsui | – |
2 investors in total: 2 institutional.
Investors in Arch Pharmalabs
Arch Pharmalabs has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Mitsui & Co and Neuland Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Traditional conglomerate services are provided across multiple sectors by Mitsui. | 1947 | mitsui.com | Chiyoda City, Japan | |
Active pharmaceutical ingredients and peptides are manufactured globally. | 1984 | neulandlabs.com | Hyderabad, India |
Investor details for Arch Pharmalabs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Arch Pharmalabs Limited (Arch Pharmalabs)
Arch Pharmalabs Limited is the primary company behind Arch Pharmalabs. The board of Arch Pharmalabs Limited currently have 6 directors; the longest-serving is Ajit Annu Kamath, appointed in 2003. 26 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajit Annu Kamath DIN 00032799 | Managing Director | 01 Nov 2003 | 22 yrs 11 mo | Arch Pharmalabs Limited |
| Rajendra Padmanabhan Kaimal DIN 00032839 | Whole-time director | 01 Nov 2003 | 22 yrs 11 mo | Arch Pharmalabs Limited |
| Sunil Mansukhlal Pitroda DIN 07028212 | Director | 02 May 2017 | 9 yrs 5 mo | Arch Pharmalabs Limited |
| Vikas Bijay Kedia DIN 00636500 | Company Secretary | 18 Nov 2017 | 8 yrs 10 mo | Arch Pharmalabs Limited |
| Ashish Mohan Ujagare DIN 00012613 | Whole-time director | 14 Jun 2018 | 8 yrs 4 mo | Arch Pharmalabs Limited |
| Anshul Gupta DIN 05017027 | IRP/RP/Liquidator | 30 Apr 2025 | 1 yr 5 mo | Arch Pharmalabs Limited |
People of Arch Pharmalabs
34 people are tracked at Arch Pharmalabs (10 in leadership, 24 in team); the tracked headcount is 412.
| Name | Role | Group |
|---|---|---|
| Chairman & Managing Director | Leadership | |
Sudhir Nagar | President Marketing | Leadership |
Philip Eappan | Vice President Operations | Leadership |
Rajesh Ayare | General Manager | Leadership |
Sivasubramanian Srinivasan | HEAD - HR & ADMN | Leadership |
Nandoo Totla | General Manager - Purchase | Leadership |
Gajanan Mane | Asst General Manager | Leadership |
Rajendra Kumar Sp | General Manager Quality Control | Leadership |
Kishor Patil | General Manager Engineering Procurement | Leadership |
Ravindra Kamath | Head, Corporate Environment, Health And Safety | Leadership |
Bijay Kumar Mandal | Production Manager | Team |
Jyoti Chauhan | Production Engineer | Team |
Dhiraj Choudhary | Deputy Manager - SAP Abap. | Team |
Anil Gawali | Group Lead | Team |
Yogita Shetty | Manager HR & Admin | Team |
Vasanth Kumar | HR | Team |
Venugopal Rao | Sr Manager QA | Team |
Sivarama Krishna P | Environment Health And Safety | Team |
A. S. Mulani | G.m./v.p.- Operations API Manufacturing | Team |
Rapture Ka | Sr. Manager - Human Resources (admin & Development ) | Team |
14 more people are available in the full profile.
Complete people profiles for Arch Pharmalabs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Arch Pharmalabs
Figures of Arch Pharmalabs Limited, the primary company behind Arch Pharmalabs, for FY 2023. Revenue was ₹1,344 Cr (+2% year on year). Net profit was ₹122 Cr (9% margin). EBITDA was ₹183 Cr (14% margin). Revenue has grown at a compounded annual rate of +27% over three years and +40% over five years.
- ₹1,344 CrRevenue · FY 2023 · +2% YoY
- ₹122 CrNet profit · 9% margin
- ₹183 CrEBITDA · 14% margin
- ₹156 CrPaid-up capital
- 412Employees (provident fund records)
- +27%Revenue CAGR, 3 years
- +40%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Arch Pharmalabs Limited are on its company page.
Detailed financial statements for Arch Pharmalabs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Arch Pharmalabs
3 dated milestones of Arch Pharmalabs across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Arch Pharmalabs is founded.
- Funding First funding round of $68.0M.
- Exit Acquired by Neuland.
Competitors of Arch Pharmalabs
Arch Pharmalabs has 9 listed competitors in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Arch Pharmalabs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Arch Pharmalabs
The website of Arch Pharmalabs (archpharmalabs.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 54% vs previous month
Websites whose visitors overlap most with Arch Pharmalabs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
acg-pam.com | acg-pam.com | 100% | – | – | – |
| suburbandiagnostics.com | 64% | 88.2K | #400,489 | View details | |
| vasudhachem.com | 38% | – | #9,995,779 | View details | |
roltamax.com | roltamax.com | 37% | – | – | – |
| cht.com | 36% | – | #293,141 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Arch Pharmalabs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Arch Pharmalabs (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Arch Pharmalabs
Complete news archive for Arch Pharmalabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arch Pharmalabs
Arch Pharmalabs was founded in 1999 and raised its 1st funding round 14 years after it was founded.
Arch Pharmalabs is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Arch Pharmalabs is a funded company, having raised a total of $68M across 1 funding round to date. The company's 1st funding round was a Series C of $68M, raised on Jan 2013.
Arch Pharmalabs has 412 employees.
The primary company behind Arch Pharmalabs, Arch Pharmalabs Limited, reported revenue of ₹1,344 Cr for FY 2023, up 2% year on year.
Arch Pharmalabs, is a provider of small molecule process chemistry, custom synthesis services and full life-cycle API and drug intermediates and manufacture for the global pharmaceutical industry. In Sep2010 Japanese conglomerate Mitsui has bought a 5 stake in Arch Pharmalabs, for around INR 65 crore and additional 25 in Sept2012 for INR 372 Crore. Mitsui bought out the stakes of ILFS Trust Co, IDBI Trusteeship Services Rainbow Fund, ICICI ventures.
Arch Pharmalabs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Arch Pharmalabs offers APIs, Intermediates, and Contract Services.
Arch Pharmalabs has 2 investors. Key investors include Mitsui & Co, and Neuland Labs.
Arch Pharmalabs operates through Arch Pharmalabs Limited.
Yes. Arch Pharmalabs was acquired by Neuland in December 2017.
The legal entities of Arch Pharmalabs currently have 7 directors, including Vikas Bijay Kedia, Rajendra Padmanabhan Kaimal, Sunil Mansukhlal Pitroda and others.